June 18, 2020 / 1:28 PM / 14 days ago

BRIEF-Hutchison China Meditech Says Fruquintinib Granted U.S. FDA Fast Track Designation

June 18 (Reuters) - Hutchison China MediTech Ltd:

* HUTCHISON CHINA MEDITECH LTD - FRUQUINTINIB GRANTED U.S. FDA FAST TRACK DESIGNATION FOR METASTATIC COLORECTAL CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below